Literature DB >> 14979318

Research subject advocate: a new protector of research participants.

Kathleen M Neill1.   

Abstract

In 2001, the National Center for Research Resources (NCRR) directed the 78 General Clinical Research Centers (GCRC) to develop a Research Subject Advocate (RSA) position. The RSA would report directly to the Principal Investigator (PI) of each GCRC and assure compliance of studies conducted on the GCRC with federal regulations and policies. Seven RSAs agreed to be interviewed about their new role. Website documents, electronic correspondence, and presentations at the first annual national meeting of RSAs were scrutinized using discursive analysis to shed light on this new organizational form and its potential for increased protection of human research participants. The RSA role actualizes the ethical principles of respect for persons, justice, and beneficence that are the foundation of the protection of research participants. The results also reveal the regulatory, institutional, collegial, and personal resources and barriers that assist the RSA in the successful implementation of the RSA role. In addition, issues important to the RSAs are described.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Legal Approach; National Center for Research Resources

Mesh:

Year:  2003        PMID: 14979318     DOI: 10.1080/714906094

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  2 in total

1.  Research subject advocacy: program implementation and evaluation at clinical and translational science award centers.

Authors:  Rhonda G Kost; Carson Reider; Julie Stephens; Kathryn G Schuff
Journal:  Acad Med       Date:  2012-09       Impact factor: 6.893

Review 2.  Research ethics education for community-engaged research: a review and research agenda.

Authors:  Emily E Anderson; Stephanie Solomon; Elizabeth Heitman; James M DuBois; Celia B Fisher; Rhonda G Kost; Mary Ellen Lawless; Cornelia Ramsey; Bonnie Jones; Alice Ammerman; Lainie Friedman Ross
Journal:  J Empir Res Hum Res Ethics       Date:  2012-04       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.